Antibodies
5 November 2007
Positive Results From Peregrine Pharmaceuticals’ Bavituximab Phase l HCV Trial Presented at AASLD Meeting3 November 2007
ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis I2 November 2007
Seattle Genetics Initiates SGN-40 Clinical Trial in Combination with Revlimid for Multiple Myeloma30 October 2007
Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody29 October 2007
Peptech successfully completes Phase I trial for PN062126 October 2007
Novel Alternative Approach to Inhibiting Insulin Growth Factor (IGF) May Provide New Treatment for Breast Cancer and Other Cancers25 October 2007
Seattle Genetics Reports Preclinical Data on SGN-40 and an Anti-CD19 Antibody-Drug Conjugate25 October 2007
CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma25 October 2007
Milatuzumab Showed Promising Therapeutic Effects Alone and Combined With CD20 Antibody in Preclinical Studies24 October 2007
ARIUS announces cancer stem cell antibody program successfully completes first toxicology study24 October 2007
Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference24 October 2007
GlaxoSmithKline And Tolerx Form Worldwide Collaboration For Development And Commercialization Of Novel Medication18 October 2007
Merck Serono Announces Joint Agreement with ImClone and Bristol-Myers Squibb for Erbitux in Japan17 October 2007
Scientists Show Monoclonal Antibody Leads to Repair of Myelin Sheath in Laboratory Study of Multiple Sclerosis16 October 2007
Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple Sclerosis12 October 2007
WILEX’ second product enters Phase III trial: IND approval from FDA for registration trial with CA9-SCAN12 October 2007
Genmab Amends HuMax-CD4 Pivotal Study in CTCLNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports